Starnberg, Germany

Wolfgang Heberle

This inventor holds 3 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1984-1987.


% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Stuttgart, DE (1986)
  • Starnberg, DE (1984 - 1987)

Company Filing History:


Years Active: 1984-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wolfgang Heberle: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang Heberle is a notable inventor based in Starnberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Heberle holds 3 patents that focus on the synthesis and application of azolylmethylcycloalkanes and azolylmethylcycloacetals. His latest patents include "Azolylmethylcycloalkanes, their preparation and their use as drugs," which describes compounds useful for treating various disorders and for crop, wood, and material protection. Another significant patent is "Azolylmethylcycloacetals, their preparation and their use as drugs," which details substances with antimycotic action.

Career Highlights

Heberle is associated with BASF Aktiengesellschaft, a leading global chemical company. His work at BASF has allowed him to explore innovative solutions in drug development and material science. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Heberle has collaborated with esteemed colleagues such as Friedrich-Wilhelm Kohlmann and Walter Wesenberg. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Wolfgang Heberle's innovative work in pharmaceutical chemistry has led to the development of important compounds with therapeutic potential. His patents reflect a commitment to advancing science and improving health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…